Literature DB >> 6660047

Familial amyloidosis with polyneuropathy. A long-term follow-up of 21 patients with special reference to gastrointestinal symptoms.

L Steen, B Ek.   

Abstract

In a longitudinal study, 21 patients with familial amyloidosis with polyneuropathy (FAP) were followed up for more than three years. Gastrointestinal symptoms ultimately evolved in all patients. In the advanced stage of the disease, 13 patients had diarrhea together with anal incontinence. Weight loss was very common and related to both malabsorption and motility disturbances with anorexia and also to muscular atrophy. Steatorrhea was found in 19 patients at least once during the follow-up. The duration of the disease was significantly correlated to fecal fat output. The conclusion was drawn that the gastrointestinal involvement in FAP is very common and of great clinical importance. The consequences of malnutrition also influence the outcome of the disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660047

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  13 in total

1.  Prealbumin: its association with amyloid.

Authors:  G G Cornwell; K Sletten; B O Olofsson; B Johansson; P Westermark
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

2.  Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study.

Authors:  Violaine Planté-Bordeneuve; Farida Gorram; Hayet Salhi; Tarik Nordine; Samar S Ayache; Philippe Le Corvoisier; Daniel Azoulay; Cyrille Feray; Thibaud Damy; Jean-Pascal Lefaucheur
Journal:  J Neurol       Date:  2016-11-22       Impact factor: 4.849

3.  Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy.

Authors:  O Suhr; A Danielsson; A Rydh; N Nyhlin; S O Hietala; L Steen
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

4.  Recent advances in the treatment of familial amyloid polyneuropathy.

Authors:  David Adams
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 5.  Small bowel amyloidosis.

Authors:  Milena Gould; Neda Zarrin-Khameh; Joseph Sellin
Journal:  Curr Gastroenterol Rep       Date:  2013-10

6.  Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells.

Authors:  M el-Salhy; O Suhr; R Stenling; E Wilander; L Grimelius
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

Review 7.  Systemic amyloidosis and the gastrointestinal tract.

Authors:  Prayman T Sattianayagam; Philip N Hawkins; Julian D Gillmore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-01       Impact factor: 46.802

8.  Pharmacological treatment for familial amyloid polyneuropathy.

Authors:  Francesca Magrinelli; Gian Maria Fabrizi; Lucio Santoro; Fiore Manganelli; Giampietro Zanette; Tiziana Cavallaro; Stefano Tamburin
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

9.  Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Torbjörn Sundström; Pontus Karling; Intissar Anan; Ole B Suhr
Journal:  BMC Gastroenterol       Date:  2015-04-25       Impact factor: 3.067

Review 10.  Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.

Authors:  David Adams; Yukio Ando; João Melo Beirão; Teresa Coelho; Morie A Gertz; Julian D Gillmore; Philip N Hawkins; Isabelle Lousada; Ole B Suhr; Giampaolo Merlini
Journal:  J Neurol       Date:  2020-01-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.